Dr. Barr is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
351 North Sumneytown Pike
Merck & Co Inc
Gwynedd, PA 19454
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1986
Johns Hopkins UniversityFellowship, Cardiovascular Disease
MedStar Health (Baltimore)Residency, Internal Medicine
Certifications & Licensure
PA State Medical License 1995 - 2018
Publications & Presentations
PubMed
- 2 citationsEfficacy and Safety of Elbasvir/Grazoprevir in Hepatitis C Virus GT1- and GT4-Infected People Aged 65 Years or Older.Steven L. Flamm, Cheng Yuan Peng, Oren Shibolet, Ronald Nahass, Peggy Hwang
Gerontology & Geriatric Medicine. 2019-01-22 - 18 citationsElbasvir/grazoprevir and sofosbuvir for hepatitis C virus genotype 3 infection with compensated cirrhosis: A randomized trial.Graham R. Foster, Kosh Agarwal, Matthew E. Cramp, Sulleman Moreea, Stephen T. Barclay
Hepatology. 2018-06-01 - 24 citationsEfficacy and safety of 12 weeks of elbasvir ± grazoprevir ± ribavirin in participants with hepatitis C virus genotype 2, 4, 5 or 6 infection: The C-SCAPE studyAshley Brown, Christophe Hézode, Eli Zuckerman, Graham R. Foster, Amany Zekry
Journal of Viral Hepatitis. 2018-05-01
Press Mentions
In What Could Be a 'Big Shift' for Cancer Treatment, mRNA Vaccine Shows Promise Against MelanomaApril 16th, 2023- Merck Gets USFDA Nod for Keytruda in Combination with Padcev to Treat Advanced or Metastatic Urothelial CancerApril 4th, 2023
- Keytruda plus Chemotherapy Reduce Risk of Endometrial CancerMarch 28th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
